Last updated on October 2018

Use of Warfarin After the First Trimester in Pregnant Women With APS


Brief description of study

Evaluation of shifting to oral vitamin K antagonist after the first trimester instead of using low molecular weight heparin (LMWH) throughout pregnancy in pregnant women with antiphospholipid syndrome (APS)

Detailed Study Description

Women will be randomly divided into two groups; one will be subjected to anticoagulant therapy by Enoxaparin throughout pregnancy and the other will be subjected to anticoagulant therapy by Enoxaparin in the first trimester then Warfarin after the first trimester until termination of pregnancy.

Clinical Study Identifier: NCT02303171

Contact Investigators or Research Sites near you

Start Over

Mohamed I Eid, Dr

Obstetrics and Gynecology Department in Mansoura University Hospital
Mansourah, Egypt
  Connect »

Mohamed I Eid, Dr

Private practice settings
Mansourah, Egypt
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.